Chris Collins, a Republican Congressman from the Buffalo area has come under scrutiny recently over his directorship at and investments in Innate Immunotherapeutics, a pharmaceutical firm based in Australia.
Collins, who is Innate's largest shareholder as well as a board member, was a champion of the 21st Century Cures Act, which will speed up clinical trials of drugs and medical devices. Collins chairs the House Subcommittee on Health and Technology.
Thanks in part to that legislation, Innate's stock has more than quintupled since August, when Collins bought an additional 4 million shares, upping his stake in the company to 17%.